Search research articles
Contact Us
Filters
Showing results (41-50 of 51) with videos related to
Page
of 6
Sort By:
Scientific Reports
|
November 3, 2021
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma
Erkuden Casales, Eva Martisova, Helena Villanueva, et al.
Molecular Cancer
|
November 29, 2022
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Daniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, et al.
JCI Insight
|
August 15, 2024
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
Iker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 3, 2025
Demonstration of SLU7 as a new cancer target
Carla Rojo, Aaron Otero, Maria Elizalde, et al.
Journal of the National Cancer Institute
|
September 21, 2006
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Susana Inogès, Mercedes Rodrìguez-Calvillo, Natalia Zabalegui, et al.
Molecular Therapy. Nucleic Acids
|
May 15, 2024
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer
Ashwathi Puravankara Menon, Helena Villanueva, Daniel Meraviglia-Crivelli, et al.
Journal of Translational Medicine
|
May 14, 2017
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Susana Inogés, Sonia Tejada, Ascensión López-Díaz de Cerio, et al.
Biomed Research International
|
October 2, 2015
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma
Daniel Tusé, Nora Ku, Maurizio Bendandi, et al.
Signal Transduction and Targeted Therapy
|
June 12, 2025
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer
Borja Ruiz-Fernández de Córdoba, Karmele Valencia, Connor Welch, et al.
Neuro-Oncology
|
January 27, 2018
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
Guillermo Aldave, Marisol Gonzalez-Huarriz, Angel Rubio, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 51) with videos related to
Sort By:
Page
of 6
Scientific Reports
|
November 3, 2021
Idiotype vaccines produced with a non-cytopathic alphavirus self-amplifying RNA vector induce antitumor responses in a murine model of B-cell lymphoma
Erkuden Casales, Eva Martisova, Helena Villanueva, et al.
Molecular Cancer
|
November 29, 2022
IL-6/STAT3 signaling in tumor cells restricts the expression of frameshift-derived neoantigens by SMG1 induction
Daniel Meraviglia-Crivelli, Helena Villanueva, Angelina Zheleva, et al.
JCI Insight
|
August 15, 2024
Combination of locoregional radiotherapy with a TIM-3 aptamer improves survival in diffuse midline glioma models
Iker Ausejo-Mauleon, Naiara Martinez-Velez, Andrea Lacalle, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|
December 3, 2025
Demonstration of SLU7 as a new cancer target
Carla Rojo, Aaron Otero, Maria Elizalde, et al.
Journal of the National Cancer Institute
|
September 21, 2006
Clinical benefit associated with idiotypic vaccination in patients with follicular lymphoma
Susana Inogès, Mercedes Rodrìguez-Calvillo, Natalia Zabalegui, et al.
Molecular Therapy. Nucleic Acids
|
May 15, 2024
CD3 aptamers promote expansion and persistence of tumor-reactive T cells for adoptive T cell therapy in cancer
Ashwathi Puravankara Menon, Helena Villanueva, Daniel Meraviglia-Crivelli, et al.
Journal of Translational Medicine
|
May 14, 2017
A phase II trial of autologous dendritic cell vaccination and radiochemotherapy following fluorescence-guided surgery in newly diagnosed glioblastoma patients
Susana Inogés, Sonia Tejada, Ascensión López-Díaz de Cerio, et al.
Biomed Research International
|
October 2, 2015
Clinical Safety and Immunogenicity of Tumor-Targeted, Plant-Made Id-KLH Conjugate Vaccines for Follicular Lymphoma
Daniel Tusé, Nora Ku, Maurizio Bendandi, et al.
Signal Transduction and Targeted Therapy
|
June 12, 2025
Dual ENPP1/ATM depletion blunts DNA damage repair boosting radioimmune efficacy to abrogate triple-negative breast cancer
Borja Ruiz-Fernández de Córdoba, Karmele Valencia, Connor Welch, et al.
Neuro-Oncology
|
January 27, 2018
The aberrant splicing of BAF45d links splicing regulation and transcription in glioblastoma
Guillermo Aldave, Marisol Gonzalez-Huarriz, Angel Rubio, et al.
Page
of 6